Stock Markets March 10, 2026

Broad Market Movers: Micron, NIO Rally as BioNTech and Palantir Slip

A cross-cap snapshot of large daily swings, from mega-caps to small-cap listings

By Maya Rios MU BABA CSCO PLTR BNTX
Broad Market Movers: Micron, NIO Rally as BioNTech and Palantir Slip
MU BABA CSCO PLTR BNTX

Tuesday’s session featured notable price moves across market-cap tiers. Semiconductor names and select automakers climbed, while several biotechnology and data analytics stocks declined. The lists below capture the largest percentage changes reported across mega-cap, large-cap, mid-cap and small-cap groups.

Key Points

  • Semiconductor and select technology names, including Micron Tech (MU) and Cisco (CSCO), posted gains in the mega-cap category.
  • Automotive-related stocks like NIO (NIO) and Rivian (RIVN) advanced following analyst activity and demand commentary.
  • Biotechnology and some software firms experienced notable declines, led by BioNTech (BNTX) and Palantir (PLTR).

Stocks showed divergent performance on Tuesday as investors reacted to company-specific updates and analyst activity. Several technology and automotive names advanced, while some healthcare and software-related companies posted declines. The movements spanned from the largest market-capitalization names down to small-cap issuers.


Mega-Cap Movers ($200B+ Market Cap)

  • Micron Tech (MU) +5.46%
  • Alibaba-exch (BABA) +3.04%
  • Cisco Sys Inc (CSCO) +2.8%
  • Palantir Technologies Inc (PLTR) -3.04%

Large-Cap Stock Movers ($10B-$200B Market Cap)

  • Biontech Se (BNTX); BioNTech tumbles over 19% on fourth quarter earnings miss -20.55%
  • Centene (CNC) -10.28%
  • NIO Inc (NIO) +9.94%
  • Rivian Automotive (RIVN); TD Cowen upgrades Rivian stock rating on R2 demand outlook +8.82%
  • Vertex Pharm (VRTX); Jefferies initiates Gilead Sciences stock with buy rating +8.8%
  • Lumentum Holdings Inc (LITE) +7.26%
  • Ciena (CIEN) +6.53%
  • Coherent (COHR) +5.29%
  • HubSpot Inc (HUBS) -6.93%
  • Fair Isaac and Comp Inc (FICO) -6.69%

Mid-Cap Stock Movers ($2B-$10B Market Cap)

  • AXT Inc (AXTI) +17.88%
  • Applied Opt (AAOI) +9.02%
  • Dynergy (DYN) +11.96%
  • 21Vianet Group (VNET) +10.21%
  • Mudrick Capital A (HYMC) +10.28%
  • SolarEdge Technologies Inc (SEDG) +8.27%
  • Oaktree Acquisition Corp (HIMS); Needham upgrades Hims and Hers stock rating on Novo partnership +8.39%
  • Crispr Therapeutics AG (CRSP); CRISPR Therapeutics plans $350M convertible notes offering -7.18%
  • United Natural Foods (UNFI); United Natural Foods beats earnings but revenue falls short -7.05%
  • Fly Leasing Ltd (FLY) -7.81%

Small-Cap Stock Movers ($300M-$2B Market Cap)

  • KemPharm Inc (ZVRA) +20.29%
  • MDC Partners Inc (STGW); Stagwell partners with AppLovin for mobile ad platform access +20.04%
  • Oxygen Biotherape (TENX) +17.97%
  • Capricor Therap (CAPR); FDA resumes review of Capricor’s Deramiocel for DMD treatment +17.53%
  • Vanda Pharmaceuticals (VNDA) +13.02%
  • National Research Corporation (NRC); NRC Health authorizes $60 million stock buyback program +12.59%
  • Unusual Machines (UMAC) +11.14%
  • W&T Offshore Inc (WTI) -14.08%
  • Mesa Laboratories (MLAB); Mesa Labs names Dr. Siddhartha Kadia as new CEO -15.67%
  • Bleichroeder Acquisition I (BACQ) -21.9%

These lists reflect the largest percentage gains and losses reported in the session across market-cap groupings. The moves include a mix of analyst-driven upgrades, corporate developments, and earnings-related reactions as noted alongside several tickers.

The article is a snapshot of day-to-day market action, cataloging prominent winners and losers without evaluating longer-term implications.

Risks

  • Earnings misses or disappointing quarterly results can produce sharp declines, as illustrated by BioNTech's -20.55% move, affecting the biotechnology sector.
  • Analyst rating changes and deal announcements can drive volatile swings in stock prices, which bears on technology and automotive-related equities.
  • Convertible note offerings and financing actions, such as CRISPR Therapeutics planning a $350 million convertible notes offering, may introduce dilution or financing risk for mid-cap biotech issuers.

More from Stock Markets

Milan Market Climbs as Technology, Financials and Industrials Lead Gains Mar 10, 2026 Goeasy Plunges After Dividend Halt and Large Vehicle-Finance Charge-offs Mar 10, 2026 Judge Orders Live Nation to Talk Settlement with States After DOJ Deal Mar 10, 2026 Polish equities rise as basic materials, banking and energy stocks lead gains Mar 10, 2026 Copenhagen market edges up as consumer goods, oil and financials lead gains Mar 10, 2026